You have 9 free searches left this month | for more free features.

Vincristine sulfate

Showing 1 - 25 of 1,519

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Blasts 5 Percent or More of Bone Marrow Nucleated Cells, Blasts 5

Withdrawn
  • Allogeneic Hematopoietic Stem Cell Transplantation Recipient
  • +7 more
  • Inotuzumab Ozogamicin
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jan 13, 2022

Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Seattle (drug, other, biological)

Completed
  • Acute Lymphoblastic Leukemia
  • Lymphoblastic Lymphoma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jun 18, 2022

Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage Trial in Houston (Clofarabine,

Recruiting
  • Acute Bilineal Leukemia
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Multiple Myeloma and Plasma Cell Tumor Trial in Buffalo (dexamethasone, doxorubicin HCl, thalidomide)

Completed
  • Multiple Myeloma and Plasma Cell Neoplasm
  • Buffalo, New York
    Roswell Park Cancer Institute
Sep 30, 2022

Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Mantle-Cell Trial in Providence (Rituximab, Bendamustine, Vincristine

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • +5 more
  • Providence, Rhode Island
    Rhode Island Hospital and The Miriam Hospital
Jul 19, 2021

B-cell Acute Lymphoblastic Leukemia Trial in Tampa, Durham, Winston-Salem (Blinatumomab)

Withdrawn
  • B-cell Acute Lymphoblastic Leukemia
  • Tampa, Florida
  • +2 more
Feb 14, 2022

Stage I Mantle Cell Lymphoma, Stage II Contiguous Mantle Cell Lymphoma, Stage II Non-Contiguous Mantle Cell Lymphoma Trial in

Active, not recruiting
  • Stage I Mantle Cell Lymphoma
  • +4 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +8 more
  • Buffalo, New York
  • +1 more
Mar 9, 2022

Leukemia Trial in Portland (cyclophosphamide, cytarabine, dexamethasone)

Terminated
  • Leukemia
  • Portland, Oregon
    OHSU Knight Cancer Institute
Dec 13, 2022

Sarcoma, Kaposi, HIV Trial in Los Angeles (Bleomycin sulfate, Vincristine sulfate, Doxorubicin HCl)

Completed
  • Sarcoma, Kaposi
  • HIV Infections
  • Bleomycin sulfate
  • +3 more
  • Los Angeles, California
    UCLA CARE Center CRS
Oct 28, 2021

MDS, de Novo, MDS, Secondary, MDS, Previously Treated Trial in Boston (Venetoclax, Azacitidine, Cytarabine)

Recruiting
  • Myelodysplastic Syndromes, de Novo
  • +10 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 23, 2023

Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia Trial in Memphis (drug, biological, radiation)

Not yet recruiting
  • Refractory Acute Lymphoblastic Leukemia
  • Relapsed Acute Lymphoblastic Leukemia
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Aug 23, 2022

Solid Tumors, Primary Brain Tumors Trial in United States (Vincristine, Irinotecan, Temozolomide)

Completed
  • Solid Tumors
  • Primary Brain Tumors
  • Hartford, Connecticut
  • +13 more
Jan 12, 2023

Acute Adult T-Cell Leukemia/Lymphoma, Adult T-Cell Leukemia/Lymphoma, Chronic Adult T-Cell Leukemia/Lymphoma Trial in United

Recruiting
  • Acute Adult T-Cell Leukemia/Lymphoma
  • +3 more
  • Atlanta, Georgia
  • +13 more
Jan 26, 2023

AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell

Completed
  • AIDS-related Diffuse Large Cell Lymphoma
  • +8 more
  • Eldoret, Kenya
  • +1 more
Sep 12, 2022

Sarcoma, Kaposi, HIV Trial in United States (Bleomycin sulfate, Vincristine sulfate, Doxorubicin HCl)

Completed
  • Sarcoma, Kaposi
  • HIV Infections
  • Bleomycin sulfate
  • +4 more
  • Los Angeles, California
  • +4 more
Oct 26, 2021

Anaplastic Large Cell Lymphoma, ALK-Negative, Anaplastic Large Cell Lymphoma, ALK-Positive, Hepatosplenic T-Cell Lymphoma Trial

Completed
  • Anaplastic Large Cell Lymphoma, ALK-Negative
  • +9 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +8 more
  • Duarte, California
  • +7 more
Nov 4, 2022

Lymphoblastic Lymphoma Trial in San Diego, Memphis (Prednisone, Vincristine, Daunorubicin)

Completed
  • Lymphoblastic Lymphoma
  • San Diego, California
  • +1 more
Jun 7, 2022

Lymphoma, Non-Hodgkin, HIV Trial in Los Angeles (Bleomycin sulfate, Vincristine sulfate, Doxorubicin HCl)

Completed
  • Lymphoma, Non-Hodgkin
  • HIV Infections
  • Bleomycin sulfate
  • +8 more
  • Los Angeles, California
    USC CRS
Oct 26, 2021

Lymphoma Trial in Scottsdale, Jacksonville, Rochester (biological, drug, genetic, other)

Active, not recruiting
  • Lymphoma
  • pegfilgrastim
  • +8 more
  • Scottsdale, Arizona
  • +2 more
Jan 7, 2022

Contiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Stage I Adult

Completed
  • Contiguous Stage II Adult Lymphoblastic Lymphoma
  • +5 more
  • Sacramento, California
    University of California Davis
Mar 8, 2022

DLBCL Unclassifiable Trial in Houston (Cyclophosphamide, Doxorubicin Hydrochloride, Etoposide)

Active, not recruiting
  • Diffuse Large B-Cell Lymphoma Unclassifiable
  • Houston, Texas
    M D Anderson Cancer Center
Feb 23, 2022

Aggressive Non-Hodgkin Lymphoma, Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma, Ann Arbor Stage II

Active, not recruiting
  • Aggressive Non-Hodgkin Lymphoma
  • +13 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Aug 18, 2022

Intraocular Retinoblastoma Trial in United States (drug, procedure, biological)

Completed
  • Intraocular Retinoblastoma
  • liposomal vincristine sulfate
  • +5 more
  • Arcadia, California
  • +10 more
Jul 12, 2021

Classic Hodgkin Lymphoma Trial (procedure, biological, drug, other, radiation)

Not yet recruiting
  • Classic Hodgkin Lymphoma
  • Biospecimen Collection
  • +19 more
  • (no location specified)
Jan 6, 2023

Leukemia Trial (cyclophosphamide, cytarabine, daunorubicin HCl)

Active, not recruiting
  • Leukemia
  • (no location specified)
Aug 16, 2021